LUMAXTECH.NSE logo

LUMAXTECH.NSE
Lumax Auto Technologies Ltd.

93
Loading...
Loading...
News
all
press releases
Brief Consumer: Primer: Exide Industries (EXID IN) - Apr 2026 and more
In this briefing: Primer: Exide Industries (EXID IN) - Apr 2026 Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 Primer: Hume Industries (HUME MK) - Apr 2026 BWMX: 1Q Review: Core Stabilizing, Tupperware Deal Up Next, Reiterate Buy Primer: Asahi Broadcasting (9405 JP) - Apr 2026 1. Primer: Exide Industries (EXID IN) - Apr 2026 Exide Industries is India's largest lead-acid battery manufacturer, strategically pivoting towards lithium-ion (Li-ion) cell production to capitalize on the electric vehicle (EV) and renewable energy storage boom. The company is undertaking significant capital expenditure to establish a 12 GWh Li-ion cell manufacturing plant through its subsidiary, Exide Energy Solutions Ltd. (EESL), which presents a substantial long-term growth opportunity but also carries execution risk and is expected to suppress free cash flow in the near term. While maintaining a dominant position in the profitable lead-acid aftermarket, which provides stable cash flows, the company faces increasing competition in the emerging Li-ion space and margin pressures from raw material price volatility.
News Placeholder
More News
News Placeholder
Brief Consumer: Primer: Exide Industries (EXID IN) - Apr 2026 and more
In this briefing: Primer: Exide Industries (EXID IN) - Apr 2026 Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 Primer: Hume Industries (HUME MK) - Apr 2026 BWMX: 1Q Review: Core Stabilizing, Tupperware Deal Up Next, Reiterate Buy Primer: Asahi Broadcasting (9405 JP) - Apr 2026 1. Primer: Exide Industries (EXID IN) - Apr 2026 Exide Industries is India's largest lead-acid battery manufacturer, strategically pivoting towards lithium-ion (Li-ion) cell production to capitalize on the electric vehicle (EV) and renewable energy storage boom. The company is undertaking significant capital expenditure to establish a 12 GWh Li-ion cell manufacturing plant through its subsidiary, Exide Energy Solutions Ltd. (EESL), which presents a substantial long-term growth opportunity but also carries execution risk and is expected to suppress free cash flow in the near term. While maintaining a dominant position in the profitable lead-acid aftermarket, which provides stable cash flows, the company faces increasing competition in the emerging Li-ion space and margin pressures from raw material price volatility.
News Placeholder
Brief India: Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 and more
In this briefing: Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Primer: Zen Technologies (ZEN IN) - Apr 2026 Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 Higher Import Prices and Modest Export Rebound to Push CAD to 1% of GDP in FY27 Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 1. Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Delta Manufacturing is a prominent Indian manufacturer of hard and soft ferrite magnets with a secondary business in textiles, facing significant financial headwinds characterized by persistent net losses and declining revenues over the past three years. Despite the challenging financial performance, the company operates within the growing Indian ferrite magnet market, which is poised to benefit from government initiatives like 'Make in India' and the increasing demand from the automotive (especially EV) and consumer electronics sectors. Key challenges for the company include intense competition, negative profitability margins, and a high valuation relative to its book value and recent performance, indicating a high-risk profile for potential investors.
News Placeholder
Brief India: Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 and more
In this briefing: Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Primer: Zen Technologies (ZEN IN) - Apr 2026 Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 Higher Import Prices and Modest Export Rebound to Push CAD to 1% of GDP in FY27 Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 1. Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Delta Manufacturing is a prominent Indian manufacturer of hard and soft ferrite magnets with a secondary business in textiles, facing significant financial headwinds characterized by persistent net losses and declining revenues over the past three years. Despite the challenging financial performance, the company operates within the growing Indian ferrite magnet market, which is poised to benefit from government initiatives like 'Make in India' and the increasing demand from the automotive (especially EV) and consumer electronics sectors. Key challenges for the company include intense competition, negative profitability margins, and a high valuation relative to its book value and recent performance, indicating a high-risk profile for potential investors.
News Placeholder
Brief India: Primer: Zen Technologies (ZEN IN) - Apr 2026 and more
In this briefing: Primer: Zen Technologies (ZEN IN) - Apr 2026 Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 Higher Import Prices and Modest Export Rebound to Push CAD to 1% of GDP in FY27 Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 Exencial Industry Tidings - 24-04-2026 1. Primer: Zen Technologies (ZEN IN) - Apr 2026 Zen Technologies is a key beneficiary of the Indian government's 'Make in India' initiative, capitalizing on the growing defense budget and the need for modernization. The company is a dominant player in the domestic defense simulation and training market, with a significant market share. The company is experiencing hyper-growth, with revenue and net income showing triple-digit compound annual growth over the last three years. This is supported by a robust and growing order book, providing strong revenue visibility. Despite impressive profitability growth, the company has reported negative operating and free cash flow in the most recent fiscal year, indicating potential pressure on working capital as it scales.
News Placeholder
Brief India: Primer: Zen Technologies (ZEN IN) - Apr 2026 and more
In this briefing: Primer: Zen Technologies (ZEN IN) - Apr 2026 Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 Higher Import Prices and Modest Export Rebound to Push CAD to 1% of GDP in FY27 Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 Exencial Industry Tidings - 24-04-2026 1. Primer: Zen Technologies (ZEN IN) - Apr 2026 Zen Technologies is a key beneficiary of the Indian government's 'Make in India' initiative, capitalizing on the growing defense budget and the need for modernization. The company is a dominant player in the domestic defense simulation and training market, with a significant market share. The company is experiencing hyper-growth, with revenue and net income showing triple-digit compound annual growth over the last three years. This is supported by a robust and growing order book, providing strong revenue visibility. Despite impressive profitability growth, the company has reported negative operating and free cash flow in the most recent fiscal year, indicating potential pressure on working capital as it scales.
News Placeholder
Brief Equities Bottom-Up: Primer: Zen Technologies (ZEN IN) - Apr 2026 and more
In this briefing: Primer: Zen Technologies (ZEN IN) - Apr 2026 Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 BQE: Landmark Year Completed; Revenue Up 61%, Adj. EBITDA Up 47% UFG: Uni-Fuels Announces Full Audited 2025 Financial Results Which Showed Strong Revenue Growth Above Our Expectations. Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 1. Primer: Zen Technologies (ZEN IN) - Apr 2026 Zen Technologies is a key beneficiary of the Indian government's 'Make in India' initiative, capitalizing on the growing defense budget and the need for modernization. The company is a dominant player in the domestic defense simulation and training market, with a significant market share. The company is experiencing hyper-growth, with revenue and net income showing triple-digit compound annual growth over the last three years. This is supported by a robust and growing order book, providing strong revenue visibility. Despite impressive profitability growth, the company has reported negative operating and free cash flow in the most recent fiscal year, indicating potential pressure on working capital as it scales.
News Placeholder
Brief Equities Bottom-Up: Primer: Zen Technologies (ZEN IN) - Apr 2026 and more
In this briefing: Primer: Zen Technologies (ZEN IN) - Apr 2026 Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 BQE: Landmark Year Completed; Revenue Up 61%, Adj. EBITDA Up 47% UFG: Uni-Fuels Announces Full Audited 2025 Financial Results Which Showed Strong Revenue Growth Above Our Expectations. Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 1. Primer: Zen Technologies (ZEN IN) - Apr 2026 Zen Technologies is a key beneficiary of the Indian government's 'Make in India' initiative, capitalizing on the growing defense budget and the need for modernization. The company is a dominant player in the domestic defense simulation and training market, with a significant market share. The company is experiencing hyper-growth, with revenue and net income showing triple-digit compound annual growth over the last three years. This is supported by a robust and growing order book, providing strong revenue visibility. Despite impressive profitability growth, the company has reported negative operating and free cash flow in the most recent fiscal year, indicating potential pressure on working capital as it scales.
News Placeholder
Brief Growth Ideas: Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 and more
In this briefing: Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 X-Energy Inc. (XE): Nuclear Play Ignites, IPO Jumps 27% on Day One Legal Tech VP Of Cloud Operations On Evaluating Legal AI Tools Healthcare Company Associate GC On Where Legal AI Products Break Down Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 1. Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 Krishna Institute of Medical Sciences (KIMS) is a leading multi-specialty healthcare provider with a strong presence in Southern India, particularly in Andhra Pradesh and Telangana. The company is known for its affordable care model and a doctor-partnership model that fosters clinical excellence. KIMS is in a significant growth phase, expanding its bed capacity through both organic and inorganic routes. This expansion into new geographies like Maharashtra and Karnataka, and the addition of new specialties, are expected to be key future growth drivers. While the company has demonstrated a strong financial track record with consistent revenue growth and healthy profitability, it faces challenges related to the integration of newly acquired hospitals, which has led to some margin compression.
News Placeholder
Brief Growth Ideas: Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 and more
In this briefing: Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 X-Energy Inc. (XE): Nuclear Play Ignites, IPO Jumps 27% on Day One Legal Tech VP Of Cloud Operations On Evaluating Legal AI Tools Healthcare Company Associate GC On Where Legal AI Products Break Down Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 1. Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 Krishna Institute of Medical Sciences (KIMS) is a leading multi-specialty healthcare provider with a strong presence in Southern India, particularly in Andhra Pradesh and Telangana. The company is known for its affordable care model and a doctor-partnership model that fosters clinical excellence. KIMS is in a significant growth phase, expanding its bed capacity through both organic and inorganic routes. This expansion into new geographies like Maharashtra and Karnataka, and the addition of new specialties, are expected to be key future growth drivers. While the company has demonstrated a strong financial track record with consistent revenue growth and healthy profitability, it faces challenges related to the integration of newly acquired hospitals, which has led to some margin compression.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available